INFORMS has awarded Microsoft (NASDAQ: MSFT) its 2026 Franz Edelman Award for Achievement in Advanced Analytics, Operations Research and Management Science, for reengineering how global cloud infrastructure is planned and delivered, applying advanced analytics and AI to orchestrate complex fulfillment decisions across its rapidly expanding data center network.
INFORMS has awarded the 2026 UPS George D. Smith Prize to the Georgia Institute of Technology (Georgia Tech). The award recognizes excellence in preparing students to become practitioners of O.R. and analytics.
In the rush to adopt artificial intelligence, many employers are now requiring that employees use AI tools. As you’re using AI, be intentional and selective. It’s critical that you know yourself. Research published in Management Science found that AI is most valuable for people who understand their own abilities and limitations. Assess yourself, so you can factor this into your process for incorporating AI into your work.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
Yuri Levin, professor of Queen’s University Smith School of Business specializing in business analytics and artificial intelligence, takes up the position of Dean of Moscow School of Management SKOLKOVO.
Julie Swann, a professor of industrial and systems engineering at North Carolina State University, who advised the CDC during the H1N1 response, said she believes North Carolina will have all of the necessary logistics in place for mass distribution of a coronavirus vaccine as soon as one if approved.
The U.S. just reached a dark milestone: 10 million reported coronavirus cases. But there is also big news for a potential coronavirus vaccine. On November 9, Pfizer and German drugmaker BioNTech announced that data from their ongoing coronavirus vaccine trial shows the vaccine is more than 90% effective in preventing COVID-19, per the New York Times.
The duo's vaccine, known as BNT162b2, proved to be 90% effective after being tested on nearly 44,000 participants in its Phase III study. This is a significant milestone in the fight against a virus that has infected more than 50 million people around the globe, resulting in over 1.2 million deaths. FOX Business takes a look at the key data points investors and consumers should know, as well as reactions from business and political leaders.
Prashant Yadav of the Center for Global Development and Tinglong Dai of Johns Hopkins University, join “Squawk on the Street” to discuss coronavirus vaccine development and distribution.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine